Obtaining of ISO-9001:2015 certification for all the Company's activities Īppointment of Sébastien BESSY as Chief Operating Marketing and Business Officer.Ĭash flow of €25.8 million as of Jįinancial visibility until the first half of 2024, excluding potential additional revenues. Launch of three clinical studies that could lead to commercialization up to 3 years ahead of the initial plan. Launch of the HEART Phase II clinical study Ĭompletion of recruitment confirmed in September.Īcceleration of the development program following the presentation of preclinical data at the annual congress of the European Society of Hypertension and the International Society of Hypertension 070, reduction of LDL-hypercholesterolemia ('bad cholesterol').

Scientific publications validating the R&D work performed Īnnouncement of the implementation of a clinical mode of action study by INAF at Laval University in Quebec City, in partnership with Nestlé Health Science. Associazioni Familiari Vittime Terrorismo e StragiĬOMUNICATO STAMPA - Responsabilità editoriale di Business Wire Valbiotis Reviews Its Activities and Publishes Its Financial Report for the First Half of 2021.ANM - Associazione Nazionale Magistrati.ANAC - Autorità Nazionale Anticorruzione.CSM - Consiglio Superiore della Magistratura.

Requirements for iso 9001 2015